Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma.
about
Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.Bladder tissue pharmacokinetics of intravesical mitomycin C and suramin in dogsPharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanesTrial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.A combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cells
P2860
Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Phase I/II trial of 5-fluorour ...... tastatic renal cell carcinoma.
@ast
Phase I/II trial of 5-fluorour ...... tastatic renal cell carcinoma.
@en
type
label
Phase I/II trial of 5-fluorour ...... tastatic renal cell carcinoma.
@ast
Phase I/II trial of 5-fluorour ...... tastatic renal cell carcinoma.
@en
prefLabel
Phase I/II trial of 5-fluorour ...... tastatic renal cell carcinoma.
@ast
Phase I/II trial of 5-fluorour ...... tastatic renal cell carcinoma.
@en
P2093
P2860
P356
P1476
Phase I/II trial of 5-fluorour ...... tastatic renal cell carcinoma.
@en
P2093
Brian I Rini
Guillaume M Wientjes
Jessie J L Au
Matthew M Cooney
Paul Elson
Ram Ganapathi
Robert Dreicer
Ronald M Bukowski
Saby George
Susan Roman
P2860
P356
10.3816/CGC.2008.N.012
P407
P577
2008-09-01T00:00:00Z